Combination Adjuvant Formulation for Balanced Immune Response
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current vaccines often rely on suboptimal adjuvants that fail to induce robust and sustained immune responses, particularly for Th1-type immune responses, necessitating the development of safer and more effective adjuvants to enhance immunogenicity and protect against infectious diseases.
Innovation Solution
A combination of host defense peptides, such as defensins or cathelicidins, with a polyanionic polymer like polyphosphazene and immunostimulatory sequences like CpG oligonucleotides or poly(I:C), which work together to enhance immune responses to co-administered antigens by stimulating both humoral and cellular immunity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If alum is used as an adjuvant, then Th2 type immune responses are induced, but Th1-type immune responses are not potentiated
Solution Approach 1:
The invention combines multiple adjuvant components (alum, CpG oligonucleotides, and emulsions) into a composite adjuvant system that simultaneously induces both Th2 and Th1-type immune responses, overcoming the limitation of alum which only induces Th2 responses
Solution Approach 2:
The patent merges different immunostimulatory mechanisms (alum-induced Th2 response, CpG-induced Th1 response, and emulsion-based adjuvanticity) into a single unified adjuvant formulation that produces balanced and potent immune responses
2Object-affected harmful factors
If killed or subunit vaccines are used, then vaccine safety is improved, but immunogenicity is reduced resulting in weak and transient T-cell responses
Solution Approach 1:
The invention introduces adjuvants as intermediary substances that mediate between the weak immunogenicity of subunit vaccines and the need for strong immune responses, using alum for Th2 induction, CpG for Th1 induction, and emulsions for enhanced antigen presentation
Solution Approach 2:
The patent modifies the immunological parameters of subunit vaccines by adding adjuvant components that change the magnitude, duration, and quality of immune responses, transforming weak transient responses into robust sustained responses
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This combination significantly increases antibody titers and confers protective immunity against various pathogens, demonstrating improved immunogenicity and safety compared to traditional adjuvants.
Implementation Method 1
Bacterial DNA, as well as synthetic CpG oligonucleotides bind to the cellular receptor Toll-Like Receptor 9 (TLR9) and stimulate a cascade of cell signaling events
Implementation Method 2
Viral components such as double stranded (ds) RNA have also been demonstrated to have potent immunostimulatory properties. dsRNA, as well as the synthetic dsRNA analog polyriboinosinic acid-polyribocytidylic acid (poly(I:C)), are recognized by TLR3 resulting in receptor activation
Data Source
AI summary
Methods and compositions for enhancing an immune response to a selected antigen are described. The methods are useful for the treatment and prevention of microbial infections, such as infections caused by bacteria, viruses, fungi and parasites. The methods and compositions include host defense peptides, polyphosphazenes and immunostimulatory sequences to enhance the immune response to a coadministered antigen.